Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Davidsson

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
The Biochemical Journal|April 1, 1988
Characterization of the binding epitope of a monoclonal antibody to sulphatideP Fredman, L Mattsson, K Andersson, et al.
Acta Neurologica Scandinavica|September 1, 1990
Circulating glycoconjugates in CSF of meningioma patientsP Davidsson, P Fredman, H von Holst, et al.
Archives of Neurology|October 1, 1991
Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'K Blennow, P Davidsson, A Wallin, et al.
Neurology|October 26, 1999
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sampleN Andreasen, L Minthon, A Clarberg, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 11, 2001
The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluidsM Bjarnadottir, C Nilsson, V Lindström, et al.
Archives of Neurology|June 16, 1999
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of diseaseN Andreasen, C Hesse, P Davidsson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 10, 2000
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal agingM Sjögren, L Minthon, P Davidsson, et al.
Neuroscience Letters|May 2, 2000
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardizationE Vanmechelen, H Vanderstichele, P Davidsson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2001
Both total and phosphorylated tau are increased in Alzheimer's diseaseM Sjögren, P Davidsson, M Tullberg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 4, 1998
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up studyN Andreasen, E Vanmechelen, A Van de Voorde, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
The Biochemical Journal|April 1, 1988
Characterization of the binding epitope of a monoclonal antibody to sulphatideP Fredman, L Mattsson, K Andersson, et al.
Acta Neurologica Scandinavica|September 1, 1990
Circulating glycoconjugates in CSF of meningioma patientsP Davidsson, P Fredman, H von Holst, et al.
Archives of Neurology|October 1, 1991
Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'K Blennow, P Davidsson, A Wallin, et al.
Neurology|October 26, 1999
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sampleN Andreasen, L Minthon, A Clarberg, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 11, 2001
The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluidsM Bjarnadottir, C Nilsson, V Lindström, et al.
Archives of Neurology|June 16, 1999
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of diseaseN Andreasen, C Hesse, P Davidsson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 10, 2000
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal agingM Sjögren, L Minthon, P Davidsson, et al.
Neuroscience Letters|May 2, 2000
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardizationE Vanmechelen, H Vanderstichele, P Davidsson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2001
Both total and phosphorylated tau are increased in Alzheimer's diseaseM Sjögren, P Davidsson, M Tullberg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 4, 1998
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up studyN Andreasen, E Vanmechelen, A Van de Voorde, et al.
Pageof 7